Conversely, MAP7 overexpression in ES-2 and OVCAR8 cells resulted in increased expression of these components (Fig. 4E and F), pointing to MAP7's role in activating the Wnt/β-catenin pathway and thereby promoting EMT in ovarian cancer cells. The gene discussed is MAP7; the disease is ovarian carcinoma.